Literature DB >> 30571137

An Integrated Transfer Learning and Multitask Learning Approach for Pharmacokinetic Parameter Prediction.

Zhuyifan Ye1, Yilong Yang1,2, Xiaoshan Li2, Dongsheng Cao3, Defang Ouyang1.   

Abstract

BACKGROUND: Pharmacokinetic evaluation is one of the key processes in drug discovery and development. However, current absorption, distribution, metabolism, and excretion prediction models still have limited accuracy. AIM: This study aims to construct an integrated transfer learning and multitask learning approach for developing quantitative structure-activity relationship models to predict four human pharmacokinetic parameters.
METHODS: A pharmacokinetic data set included 1104 U.S. FDA approved small molecule drugs. The data set included four human pharmacokinetic parameter subsets (oral bioavailability, plasma protein binding rate, apparent volume of distribution at steady-state, and elimination half-life). The pretrained model was trained on over 30 million bioactivity data entries. An integrated transfer learning and multitask learning approach was established to enhance the model generalization.
RESULTS: The pharmacokinetic data set was split into three parts (60:20:20) for training, validation, and testing by the improved maximum dissimilarity algorithm with the representative initial set selection algorithm and the weighted distance function. The multitask learning techniques enhanced the model predictive ability. The integrated transfer learning and multitask learning model demonstrated the best accuracies, because deep neural networks have the general feature extraction ability; transfer learning and multitask learning improve the model generalization.
CONCLUSIONS: The integrated transfer learning and multitask learning approach with the improved data set splitting algorithm was first introduced to predict the pharmacokinetic parameters. This method can be further employed in drug discovery and development.

Entities:  

Keywords:  ADME; deep learning; multitask learning; pharmacokinetic parameters; transfer learning

Mesh:

Year:  2019        PMID: 30571137     DOI: 10.1021/acs.molpharmaceut.8b00816

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Machine Learning Attempts for Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies.

Authors:  Hao Lou; Michael J Hageman
Journal:  Pharm Res       Date:  2021-03-12       Impact factor: 4.200

2.  Are 2D fingerprints still valuable for drug discovery?

Authors:  Kaifu Gao; Duc Duy Nguyen; Vishnu Sresht; Alan M Mathiowetz; Meihua Tu; Guo-Wei Wei
Journal:  Phys Chem Chem Phys       Date:  2020-04-29       Impact factor: 3.676

3.  Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study.

Authors:  Pius T Mpiana; Koto-Te-Nyiwa Ngbolua; Damien S T Tshibangu; Jason T Kilembe; Benjamin Z Gbolo; Domaine T Mwanangombo; Clement L Inkoto; Emmanuel M Lengbiye; Clement M Mbadiko; Aristote Matondo; Gedeon N Bongo; Dorothée D Tshilanda
Journal:  Chem Phys Lett       Date:  2020-06-30       Impact factor: 2.328

Review 4.  Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches.

Authors:  Hyunho Kim; Eunyoung Kim; Ingoo Lee; Bongsung Bae; Minsu Park; Hojung Nam
Journal:  Biotechnol Bioprocess Eng       Date:  2021-01-07       Impact factor: 3.386

5.  Prediction of small-molecule compound solubility in organic solvents by machine learning algorithms.

Authors:  Zhuyifan Ye; Defang Ouyang
Journal:  J Cheminform       Date:  2021-12-11       Impact factor: 5.514

6.  Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors.

Authors:  Mabrouk Horchani; Niels V Heise; René Csuk; Hichem Ben Jannet; Abdel Halim Harrath; Anis Romdhane
Journal:  Molecules       Date:  2022-08-19       Impact factor: 4.927

Review 7.  Digital Pharmaceutical Sciences.

Authors:  Safa A Damiati
Journal:  AAPS PharmSciTech       Date:  2020-07-26       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.